Switching from Chlorpromazine to Olanzapine

Recommended Switching Protocol

The American College of Cardiology is not applicable here, however, a gradual cross-titration protocol over 1-2 weeks is recommended, starting olanzapine at 2.5-5 mg daily while simultaneously reducing chlorpromazine by 50%, then titrating olanzapine to a target dose of 5-10 mg daily while discontinuing chlorpromazine completely by week 2 1
Start olanzapine at 2.5-5 mg orally once daily, preferably at bedtime due to its sedating properties 2, 3
Increase olanzapine to target therapeutic dose of 5-10 mg daily based on symptom response and tolerability 3, 4

Assess psychotic symptoms weekly using standardized scales to detect any symptom exacerbation during the transition 1
Monitor orthostatic vital signs at each visit, as both medications can cause orthostatic hypotension, though chlorpromazine carries higher risk 2, 3
Watch for extrapyramidal symptoms (EPS), noting that olanzapine has lower EPS risk than chlorpromazine 2, 4
Evaluate sedation levels, as both agents are sedating but olanzapine may cause less severe sedation 2, 3

Assess metabolic parameters including weight, fasting glucose, and lipid panel, as olanzapine carries significant metabolic risk with long-term use 3
Monitor for anticholinergic effects, though olanzapine is less anticholinergic than chlorpromazine 2
Evaluate for drowsiness and orthostatic hypotension, which are common with olanzapine 3, 4

For older or frail patients, start olanzapine at the lower end of the dosing range (2.5 mg daily) and titrate more gradually 3
Reduce doses in patients with hepatic impairment 3
Use a slower cross-titration closer to 2-3 weeks rather than 1-2 weeks to minimize risk of decompensation 1